Back to Search
LOUIS AURISICCHIO, M.D.
M.D.
Gastroenterology Physician
NPI: 1235155482IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
1806671(NY)
Education
OTHER
Class of 1987
Research & Publications (20)
MMP11: a novel target antigen for cancer immunotherapy.
PMID 19509157·Clin Cancer Res·2009
7-preclinical
Coadministration of telomerase genetic vaccine and a novel TLR9 agonist in nonhuman primates.
PMID 19623161·Mol Ther·2009
7-preclinical
Engineered adenovirus serotypes for overcoming anti-vector immunity.
PMID 19645630·Expert Opin Biol Ther·2009
6-review
Antiapoptotic small interfering RNA as potent adjuvant of DNA vaccination in a mouse mammary tumor model.
PMID 19222350·Hum Gene Ther·2009
7-preclinical
Treatment of mammary carcinomas in HER-2 transgenic mice through combination of genetic vaccine and an agonist of Toll-like receptor 9.
PMID 19240169·Clin Cancer Res·2009
7-preclinical
ErbB2 genetic cancer vaccine in nonhuman primates: relevance of single nucleotide polymorphisms.
PMID 19257854·Hum Gene Ther·2009
7-preclinical
Comparative expression pathway analysis of human and canine mammary tumors.
PMID 19327144·BMC Genomics·2009
4-observational
A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses.
PMID 19561534·J Immunother·2009
7-preclinical
A therapeutic cancer vaccine targeting carcinoembryonic antigen in intestinal carcinomas.
PMID 18937552·Hum Gene Ther·2009
7-preclinical
An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models.
PMID 18989354·Cancer Gene Ther·2009
7-preclinical
A novel chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines.
PMID 19162112·Vaccine·2009
7-preclinical
A multi-DNA preventive vaccine for p53/Neu-driven cancer syndrome.
PMID 19215191·Hum Gene Ther·2009
7-preclinical
Synergistic effect of gene-electro transfer and adjuvant cytokines in increasing the potency of hepatitis C virus genetic vaccination.
PMID 18655231·J Gene Med·2008
7-preclinical
CD4+CD25+ regulatory T-cell-inactivation in combination with adenovirus vaccines enhances T-cell responses and protects mice from tumor challenge.
PMID 17053815·Cancer Gene Ther·2007
7-preclinical
Immunogenicity and safety of a DNA prime/adenovirus boost vaccine against rhesus CEA in nonhuman primates.
PMID 17304509·Int J Cancer·2007
7-preclinical
Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1*01 transgene: a model of SCID-hu mouse for vaccine development.
PMID 17662890·Exp Hematol·2007
7-preclinical
Vectors encoding carcinoembryonic antigen fused to the B subunit of heat-labile enterotoxin elicit antigen-specific immune responses and antitumor effects.
PMID 18055074·Vaccine·2007
7-preclinical
Genetic vaccines against Ep-CAM break tolerance to self in a limited subset of subjects: initial identification of predictive biomarkers.
PMID 16619291·Eur J Immunol·2006
7-preclinical
Individual mouse analysis of the cellular immune response to tumor antigens in peripheral blood by intracellular staining for cytokines.
PMID 17010367·J Immunol Methods·2006
7-preclinical
DNA and adenoviral vectors encoding carcinoembryonic antigen fused to immunoenhancing sequences augment antigen-specific immune response and confer tumor protection.
PMID 16409127·Hum Gene Ther·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 672 STONELEIGH AVE
CARMEL, NY 10512 - Phone
- (845) 279-2000
Quick Facts
- NPI
- 1235155482
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile